Your session is about to expire
← Back to Search
N/A
Limb Immobilization for Muscle Atrophy
N/A
Recruiting
Led By Micah Drummond, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age between 18-35 and 60-85 yrs
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and after 2 weeks of leg immobilization
Awards & highlights
Study Summary
This trial is testing how well muscles recover after being inactive for a while. 45 healthy people will be in the study for 1-2 months, with tests before and after a 2-week period where they won't use one of their limbs.
Who is the study for?
Healthy individuals aged 18-35 and 60-85 can join this study on muscle health recovery after inactivity. Participants must be able to consent and live independently. Exclusions include a risk of blood clots, certain blood disorders, implanted electronic devices, recent steroid use, hormone treatments, pregnancy, staff under the investigator's supervision, or any condition deemed exclusionary by the lead researcher.Check my eligibility
What is being tested?
The trial studies how muscles recover from a period of not being used (limb immobilization) over 1-2 months in two age groups. It involves testing before and after keeping a limb still for two weeks among 45 participants to understand muscle atrophy during disuse and subsequent recovery.See study design
What are the potential side effects?
While there are no direct side effects from the interventions since it involves limb immobilization rather than medication or surgery, potential risks may include discomfort due to immobility and temporary loss of muscle strength.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am either between 18-35 years old or 60-85 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and after 2 weeks of leg immobilization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and after 2 weeks of leg immobilization
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Leg Muscle Strength
Thigh Muscle Volume
Trial Design
1Treatment groups
Experimental Treatment
Group I: Limb immobilizationExperimental Treatment1 Intervention
Participants will undergo a 2-week leg immobilization period
Find a Location
Who is running the clinical trial?
University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,644 Total Patients Enrolled
Micah Drummond, PhDPrincipal InvestigatorUniversity of Utah
1 Previous Clinical Trials
20 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently on blood thinner medication.I have had a stroke that affected my ability to move.I have a history of thyroid or diabetes issues.I have a history of kidney disease or failure.Your blood pressure is very high, with the top number (systolic pressure) being over 150 or the bottom number (diastolic pressure) being over 100.I am at risk for blood clots due to family history or certain blood conditions.I haven't taken long-term steroids in the last month.I haven't taken androgens or growth hormones in the last 6 months.I am either between 18-35 years old or 60-85 years old.I have had a GI bleed in the last year.I have a condition affecting my blood vessels.I have cancer or was treated for cancer, other than skin cancer, less than a year ago.You are currently following a diet to lose weight.I have a history of liver disease.I have a history of lung problems or recent upper respiratory infection.I have a history of heart disease.
Research Study Groups:
This trial has the following groups:- Group 1: Limb immobilization
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many patients is this trial currently accommodating?
"Confirmed. Clinicaltrials.gov data substantiates that this clinical trial, first put up on May 15th 2022, is still recruiting patients and requires 45 participants from 1 medical site."
Answered by AI
Are octogenarians eligible to apply for this research initiative?
"In order to be enrolled in this trial, potential participants must meet the age criteria of 18 years or older and 85 years or younger."
Answered by AI
Are there any vacancies to take part in this clinical trial?
"Affirmative. According to clinicaltrials.gov, recruitment for this study is ongoing as of June 17th 2022; the trial was initially listed on May 15th 2022 and necessitates 45 subjects from a single research centre."
Answered by AI
Is it possible for me to partake in this clinical research?
"This clinical trial is searching for 45 patients with muscle disuse between the ages of 18-85. Those hoping to participate must meet these eligibility criteria."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger